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 Vitamin C (VitC) is a potent antioxidant and contributes as an apoptosis inhibitor by preventing death receptor-
triggered caspase 8 activity. Fas ligand (FasL) induces the apoptotic cell death via activation of Fas signaling, which 
is dependent on the expression level of anti-apoptotic molecule c-FLIP (FADD-like IL-1beta-converting enzyme-
inhibitory proteins). The present study addressed the effects of VitC on survival of dendritic cells (DCs), a 
regulator of innate and adaptive immunity. To this end, mouse bone marrow cells were isolated and cultured to 
attain bone marrow-derived DCs (BMDCs). The cells were treated with FasL in the presence or absence of 
VitC. Real time RT-PCR, Western blotting and FACS analysis were performed to determine different hallmarks of 
DC apoptosis. As a result, FasL treatment resulted in activation of caspase 8 and stimulation of cell membrane 
scrambling, the effects were supressed when VitC was present in the cell culture or the cells were transfected 
with FLIP siRNA. In conclusion, VitC prevented FasL-triggered DC apoptosis mediated through the 
expression of c-FLIP. 
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INTRODUCTION 
 Dendritic cells (DCs) are the most potent 
antigen-presenting cells in the immune system. After 
capture of foreign antigens, they migrate to the 
lymphoid organs where DCs become mature and 
present antigens to naïve T cells to elicit the effective 
adaptive immune response (Llanos et al., 2011; 
Xuan et al., 2016). These mature DCs are then 
induced to undergo apoptosis and disappear from the 
lymph nodes (LNs) (Llanos et al., 2011; Xuan et al., 
2016).  The apoptosis is initiated through two major 
apoptotic pathways: the death receptor-mediated 
extrinsic pathway and the mitochondrial-involved 
intrinsic pathway (Martino, 2007).  
 The death receptor-mediated DC apoptosis is 
triggered by a binding with respective ligand, 
leading to the programed cell-death (Xuan et al., 
2010). A death receptor named Fas is abundantly 
expressed on immature DCs and significantly 
increased when the cells mature (Ashany et al., 
1999). The interaction of Fas and Fas ligand (FasL) 
induces differentiation of naïve T cells by activation 
of intracellular signalling pathways in DCs (Suss et 
al., 1996) and is followed by activation of cysteinyl 
aspartate-specific protease (caspase) cascade and 
suicidal cell death (Buonocore et al., 2002). The 
sensitivity levels of Fas-triggered apoptosis is 
dependent on the expression of c-FLIP (FADD-like 
IL-1beta-converting enzyme-inhibitory proteins) 
(Golan-Gerstl et al., 2012), whose level is regulated 
by TRAIL (TNF-related apoptosis-inducing ligand 
(Sun et al., 2015), BIN1 (bridging integrator 1) 
(Esmailzadeh et al., 2015) and estradiol (Jaita et al., 
2016). The c-FLIP elicits anti-inflammatory effects 
by supressing transcription of inflammation-related 
genes such as tumor necrosis factor (TNF)-α and 
interleukin (IL)-2, which are secreted by mature 
DCs, therefore this protein contributes as an inhibitor 
of mouse DC maturation and activation (Wu et al., 
2015). 
 The effect of c-FLIP on the apoptotic death is 
different from other cell types. This protein 
participates in inhibiting extrinsic apoptotic 
pathways by preventing the activation of caspase 8 
in mouse embryonic fibroblasts (Conti et al., 2016), 
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whereas its effect on caspase-8 activity in mouse 
DCs is not observed (Wu et al., 2015). In addition to 
its effects on the death receptor-dependent pathway, 
the expression of c-FLIP is also involved in 
protection against the apoptotic intrinsic pathway, a 
mitochondrion-dependent apoptosis regulated by 
Bcl-2 family proteins in human melanoma cells 
(Hamai et al., 2006). Increased expression of anti-
apoptotic molecules and decreased expression of 
pro-apoptotic molecule blocks the mitochondrial 
depolarization (Lucken-Ardjomande et al., 2005) to 
promote cell survival.  
 Vitamin C (VitC) is well known as natural 
antioxidant and plays a role in counteracting 
oxidative stress and cellular damage by scavenging 
oxygen-derived free radicals including ROS 
(reactive oxygen species) production (Habu et al., 
2015). Thus, VitC has been described as an inhibitor 
of the programed cell death. VitC supplementation 
blocks Fas-mediated apoptosis through reduced 
activity of caspase cascade and diminished level of 
ROS in cancer cells as well as in human monocytes 
(Jeong et al., 2016; Perez-Cruz et al., 2003). 
Moreover, VitC functions as a stimulator of immune 
response by eliciting some anti-inflammatory 
activity in DCs (Jeong et al., 2014; Kim et al., 2012). 
By the presence of VitC mature DCs produce 
enhanced level of IL-12p70 to promote the 
differentiation of CD8+ memory T cell (Jeong et al., 
2014) and VitC upregulates expression of 
costimulatory and antigen-presenting molecules in 
DC line (Kim et al., 2012).  
 Although the anti-apoptotic effect of VitC on 
other cells is well documented, the effect of VitC on 
apoptosis of DCs has not been reported. Thus, the 
present study explored whether VitC influences 
survival of DCs. To this end, bone marrow derived 
mouse DCs (BMDCs) were treated with FasL in the 
presence or absence of VitC and different hallmarks 
of apoptosis were determined. 
MATERIALS AND METHODS 
Mice  
 Wild type pathogen-free BALB/c mice at the 
age of 6 to 8 weeks were purchased from Taconic 
Farms (Hudson, NY, USA) and housed in a specific 
pathogen-free facility at Institute of Genome 
Research. The animals had free access to food and 
drinking water. Animal care and experimental 
procedures were performed according to the 
Vietnamese law for the welfare of animals and were 
approved by the ethical committee of Institute of 
Genome Research. 
Bone marrow-derived DCs 
 BALB/c mice were anesthetized with isoflurane 
gas and bone marrow cells were flushed out of the 
cavities from the femur and tibia with sterile PBS 
(pH=7.4). Cells were washed twice with RPMI-1640 
and seeded out at a density of 4 x 106 cells per 60-mm 
dish. Cells were cultured for 8 days in RPMI-1640 
(GIBCO, Grand Island, NY, USA) containing: 10% 
FCS, 1% penicillin/streptomycin, 1% glutamine, 1% 
non-essential amino acids (NEAA) and 50 µm β-
mercaptoethanol. Cultures were supplemented with 
GM-CSF (35 ng/mL, Sigma Aldrich, St. Louis, MO, 
USA) and fed with fresh medium containing GM-CSF 
on days 3 and 6. Nonadherent and loosely adherent 
cells were harvested after 8 days of culture. 
Experiments were performed on days 8-10. BMDCs 
were treated with FasL (500 ng/ml, Sigma Aldrich, St. 
Louis, MO, USA) in the presence or absence of VitC 
(100 ng/ml, Sigma Aldrich). 
FLIP small interfering RNA (siRNA)  
 FLIP-targeted siRNA (Santa Cruz) was 
transfected into DCs (105 cells/ 1ml) at a final 
concentration of 100 nM using Nucleofector 
technology (Lonza, GA, USA) according to the 
manufacturer’s recommendations. After 
electroporation, cells were incubated for 24 h at 
37°C, 5% CO2. After washing three times with PBS 
the cells were treated for 24 h with FasL in the 
presence or absence of VitC. 
RNA extraction and real-time RT-PCR 
 Total RNA was isolated from mouse DCs by 
using the Qiashredder and RNeasy Mini Kit from 
Qiagen. For cDNA first strand synthesis, 1 µg of 
total RNA in 12.5 µl DEPC-H2O was mixed with 1 
µl of oligo-dT primer (500 µg/ml, Invitrogen, 
Carlsbad, CA, USA) and heated for 2 min at 70°C. 
To determine c-FLIP transcript levels, quantitative 
real-time PCR with the LightCycler System (Roche, 
Basel, Switzerland) was applied. The following 
primers were used: FLIP primers (sc-35389-PR, 
Santa Cruz, Dallas, Texas, USA) and actin primers: 
5’-CATTGCTGACAGGATGCAGAA-3’ (forward) 
and 5’-ATGGTGCTAGGAGCCAGAGC-3’ 
(reverse). PCR reactions were performed in a final 
volume of 20 µl containing 2 µl cDNA, 2.4 µl 
MgCl2 (3 µM), 1 µl primer mix (0.5 µM of both 
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primers), 2 µl cDNA Master SybrGreen I mix 
(Roche), and 12.6 µl DEPC-treated water. The target 
DNA was amplified during 40 cycles of 95ºC for 10 
s, 60ºC for 10 s, and 72ºC for 16 s, each with a 
temperature transition rate of 20ºC/s, a secondary 
target temperature of 50ºC, and a step size of 0.5ºC. 
Melting curve analysis was performed at 95ºC, 0 s; 
60ºC, 10 s; 95ºC, 0 s to determine the melting 
temperature of primer dimers and the specific PCR 
products. The ratio between the respective gene and 
corresponding β-actin was calculated per sample 
according to the ∆∆ cycle threshold method (Livak 
et al., 2001). 
Immunoblotting 
 DCs (2*106 cells) were washed twice in PBS, 
then solubilized in lysis buffer (Thermo Fisher, 
Waltham, MA, USA) containing protease inhibitor 
cocktail (Sigma-Aldrich). Samples were stored at -
80°C until use for western blotting. Cell lysates were 
separated by 10% SDS-PAGE and blotted on 
nitrocellulose membranes. The blots were blocked 
with 5% nonfat-milk in triethanolamine-buffered 
saline (TBS) and 0.1% Tween-20. Then the blots 
were probed overnight with monoclonal antibodies 
directed against either c-FLIPL or GAPDH (Cell 
signalling, Danvers, MA, USA) diluted 1:1000 in 
blocking buffer, washed 5 times, probed with 
secondary antibodies (anti mouse or anti-rabbit, GE 
healthcare) diluted 1:5000 for 1 h at room 
temperature and washed final 5 times. Antibody 
binding was detected with the enhanced 
chemiluminescence (ECL) kit (GE Healthcare, 
Chicago, Illinois, USA). Densitometer scans of the 
blots were performed using Quantity One (BioRad, 
Hercules, California, USA). 
Caspase 8 activity assay 
 Caspase 8 activity was determined using a 
Caspase-8 fluorometric assay kit from Biovision 
(Milpitas, CA, USA) according to the 
manufacturer’s instructions. Briefly 1x106 cells were 
washed twice with cold PBS, fixed and 
permeabilized with ‘Cytofix/Cytoperm’ solution and 
then washed twice with ‘Perm/ Wash’ buffer. Then 
cells were stained with FITC conjugated anti-active 
Caspase 8 antibody in ‘Perm/ Wash’ buffer for 60 
minutes. After 2 washing steps, the cells were 
analyzed by flow cytometry (FACS Aria Fusion, BD 
Biosciences, San Jose, CA, USA). 
Phosphatidylserine translocation 
 Apoptotic cell membrane scrambling was 
evidenced from annexin V binding to 
phosphatidylserine (PS) at the cell surface. The 
percentage of PS-translocating cells was evaluated 
by staining with fluorescein isothiocyanate (FITC)-
conjugated Annexin V. In brief 5 x105 cells were 
harvested and washed twice with Annexin washing 
buffer (AWB). The cell pellet was resuspended in 
100 µl of Annexin-V-Fluos labelling solution 
(Roche) (20µl Annexin-V-Fluos labelling reagent in 
1 ml AWB) and incubated for 15 min at room 
temperature. After washing with AWB, the cells 
were analyzed by flow cytometry.  
Statistics  
 Data are provided as means ± standard error of the 
mean (SEM). All experiments were performed at least 
three times. Statistical significance was determined 
using ANOVA. For all statistical analysis, *P < 0.05, 
**P < 0.01, and ***P < 0.001 were considered 
statistically significant. 
RESULTS 
Effect of VitC on the expression of c-FLIP in DCs  
 The expression level of c-FLIP has been 
determined to involve in resistance to Fas-induced 
cell death (Golan-Gerstl et al., 2012; Wajant, 2003). 
To explore the modulation effect of VitC on c-FLIP 
expression, BMDCs were cultured with GM-CSF for 8 
days and subsequently treated with FasL in the 
presence or absence of VitC. The results are in 
accordance to data of Wajant et al. (Wajant, 2003) that 
treatment of the cells with FasL down-regulated the c-
FLIP transcript level (Figure 1A) and protein (Figure 
1BC), the effects were suppressed by the presence of 
VitC (Figure 1A-C), indicating the promoting role of 
VitC on c-FLIP expression in DCs. 
Effect of VitC on caspase 8 activity in DCs 
 VitC participates in regulating the transcription 
of apoptosis-related genes (Jeong et al., 2014; Kim et 
al., 2012). Our study showed the inhibitory effect of 
VitC on the activation of caspase 8. Accordingly, 
treatment of cells with FasL in the absence of VitC 
for 24h was followed by activation of caspase 8 and 
the activity of this caspase was dramatically reduced 
when the cells were exposed with VitC (Figure 2A-
B). In addition, to ask whether the regulation of the 
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caspase 8 activation is mediated by c-FLIP expression, 
BMDCs were transfected with FLIP siRNA and 
followed by treatment with FasL in the presence or 
absence of VitC for 24h. The expression c-FLIP was 
dramatically reduced in FLIP-silenced DCs (Figure 
2C). The downregulation of c-FLIP expression 
abolished FasL-induced caspase 8 activity (Figure 2A-
B), suggesting that caspase 8 activity induced by FasL 
in the absence of VitC was dependent on the 
expression of c-FLIP in BMDCs. 
 
 
Figure 1. Effect of VitC on the expression of c-FLIP in DCs. (A) Arithmetic means ± SEM (n = 5) of c-FLIP transcript level 
detected by real-time PCR analysis in DCs were treated either without (white bar) or with FasL in the absence (black bar) or 
in the presence (grey bar) of VitC using β-actin as a reference gene. (B) Original Western blot of DCs, which were either 
treated with FasL in the absence or presence of VitC or left untreated (control). Protein extracts were analyzed by Western 
blotting using antibody directed to c-FLIPL. Protein loading was controlled by GAPDH antibody. (C) Arithmetic mean ±SEM (n 
= 4) of the abundance of c-FLIP protein as the ratio of c-FLIP /GAPDH. *(p<0.05) represent significant difference from 
control condition, ANOVA. 
 
 
Figure 2. Effect of VitC on caspase 8 activity in DCs. (A) Histograms of caspase 8 activity as obtained by FACS analysis in a 
representative experiment on control- (1st and 2nd panels) and FLIP-silenced (1st and 3rd panels) DCs were either treated 
without or with FasL in the absence or presence of VitC. (B) Arithmetic means ± SEM (n = 4-6) of the percentage of control- 
(left bars) and FLIP-silenced (right bars) DCs with activated caspase 8. (C) Original Western blot of DCs, which were either 
treated with c-FLIP siRNA or left untreated (control). Protein extracts were analyzed by Western blotting using antibody 
directed to c-FLIPL. Protein loading was controlled by GAPDH antibody. ** (p<0.01) represent significant difference from 
control condition and # (p<0.05) represent significant difference from FasL-treated DCs, ANOVA. 
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Effect of VitC on cell membrane scrambling in 
DCs  
 The activation of caspases is expected to trigger 
DC apoptosis. Thus, next experiments were 
performed to ask, whether FasL triggered the cell 
membrane scrambling reflecting PS exposure at the 
cell surface. The PS exposure was determined from 
annexin V binding. As illustrated in Figure 3A-B, 
exposure of DCs to FasL was followed by 
stimulation of annexin V binding, the effect was 
reversed when VitC was present in the cell culture. 
Similarly, the increased annexin V binding in FasL-
treated DCs was also blocked when the cells were 
transfected with FLIP siRNA (Figure 3A-B). 
Therefore, the annexin V binding stimulated by FasL 
in the absence of VitC was sensitive to the 
appearance of c-FLIP. 
 
Figure 3. Effect of VitC on cell membrane scrambling in 
DCs. (A) Histograms of annexin V binding as obtained by 
FACS analysis in a representative experiment on control- 
(1st and 2nd panels) and FLIP-silenced (1st and 3rd panels) 
DCs were either treated without or with FasL in the absence 
or presence of VitC. (B) Arithmetic means ± SEM (n = 4-6) 
of the percentage of control- (left bars) and FLIP-silenced 
(right bars) DCs with annexin V binding. * (p<0.05) 
represent significant difference from control condition and # 
(p<0.05) represent significant difference from FasL-treated 
DCs, ANOVA. 
DISCUSSION  
 The present study reveals that treatment of DCs 
with FasL in the absence of VitC caused the 
apoptotic cell death as was evidenced by activation 
of caspase 8 and PS exposure. VitC has been 
reported to enhance maturation and differentiation of 
leukocytes including DCs (Jeong et al., 2014; Kim et 
al., 2012) through the modulation of mitogen-
activated protein kinases (MAPK) and 
phosphatidylinositol 3-kinase (PI3K)/Akt pathways 
(Kim et al., 2012). Besides, the role of VitC in 
preventing the ROS-mediated apoptosis are 
determined in many cell types including cancer cells 
and human monocytes (Jeong et al., 2016; Jin et al., 
2014; Perez-Cruz et al., 2003). However, its effects 
on the survival of DC have not been reported yet. 
Similarly to VitC, two members of the TNF family 
including CD40L and tumor necrosis factor (TNF)-
related activation-induced cytokine (TRANCE) have 
been shown to stimulate the activation of FasL-
dependent NF-κB pathway leading to upregulation 
of anti-apoptotic molecules such as Bcl-2 and Bcl-xL 
(Ouaaz et al., 2002) and c-FLIPs (Tschopp et al., 
1998), facilitating DC survival.  
 Several studies have indicated the inhibitory role 
of c-FLIP from the pro-apoptotic effects in many cell 
types including human DCs (Hamai et al., 2006; Wu 
et al., 2015), whereas our study indicated the 
mediating role of c-FLIP on the modulation of FasL-
triggered DC apoptosis. Clearly, the activation of 
intracellular signalling pathways in human DCs and 
mouse DCs results in different expression levels in 
the transcriptional productions. The PI3K pathway is 
considered as an inhibitor of TLR4-mediated 
inflammatory response in mouse DCs (Shumilina et 
al., 2007), whereas activation of this pathway results 
in increased production of inflammatory cytokines in 
human DCs (Liu et al., 2011). In addition, c-FLIP is 
described as a stimulator of NF-κB-dependent 
intracellular signalling pathways (Micheau et al., 
2001; Tschopp et al., 1998) allowing the cell 
maturation and differentiation in immune response 
(Haverkamp et al., 2014). Therefore, it would be 
expected to be a stimulator of cell activation leading 
to mature DCs, which are induced to undergo the 
cell death. Similar to our observation, treatment of 
cells with FasL suppresses the expression of c-FLIP 
(Wajant, 2003), the effect was abolished when VitC 
was present in the cell culture. Accordingly, the 
promoting effect of VitC on the expression level of 
c-FLIP in this finding would turn out to contribute to 
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DC activation and maturation rather than DC 
apoptosis.  
 Besides, the molecular mechanism underlying 
the regulation of Fas-mediated apoptosis is still 
unclear. The induction of the apoptosis by ligation of 
Fas with anti-Fas antibody in B cell and 
macrophages has been determined (Ashany et al., 
1995; Richardson et al., 1994), whereas other studies 
have indicated that the interaction between Fas and 
FasL results in activation of caspase cascade and 
suicidal cell death (Buonocore et al., 2002; Tschopp 
et al., 1998). Consistently, FasL was observed to 
stimulate caspase 8-dependent PS exposure and VitC 
supressed these effects (Figure 2-3). Similarly, 
several researches indicated that VitC participates in 
regulating the expression of some genes involved in 
apoptosis (Levy et al., 1996; Perez-Cruz et al., 2003; 
Vissers et al., 2004).  
 
CONCLUSION 
VitC inhibited FasL-mediated DC apoptosis is 
expected to exert some anti-inflammatory action and 
promote the immune response, an effect may apply 
its use in the treatment of inflammatory disorders 
and cancer. In any case, the inhibition of caspase 
activation and apoptotic death of DCs by VitC is 
expected to promote the immune response. 
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VITAMIN C ỨC CHẾ QUÁ TRÌNH APOPTOSIS GÂY RA BỞI FASL TRONG TẾ BÀO 
TUA THÔNG QUA BIỂU HIỆN GEN C-FLIP 
 
Nguyễn Thị Xuân, Lê Thị Thu Hiền 
Viện Nghiên cứu hệ gen, Viện Hàn lâm Khoa học và Công nghệ Việt Nam 
TÓM TẮT 
 Vitamin C (VitC) là chất chống oxy hóa mạnh và có vai trò như một chất ức chế quá trình apoptosis bằng 
cách ngăn chặn hoạt động của caspase 8. Fas ligand (FasL) gây ra sự chết tế bào theo chương trình thông qua 
hoạt động của tín hiệu Fas và phụ thuộc vào mức độ biểu hiện của gen c-FLIP. Trong nghiên cứu này, chúng 
tôi đã tiến hành xác định ảnh hưởng của VitC đến với sự sống sót của tế bào tua (TBT), tế bào này có vai trò 
điều hòa miễn dịch bẩm sinh và miễn dịch thu được. Vật liệu sử dụng là tế bào tủy xương chuột được nuôi cấy 
để thu được các tế bào tua có nguồn gốc từ tủy xương và được xử lý với FasL và VitC. Kỹ thuật nghiên cứu 
gồm real time RT-PCR, western blotting và phân tích tế bào theo dòng chảy được tiến hành để xác định các 
marker khác nhau của quá trình apoptosis. Kết quả nhận được cho thấy, xử lý tế bào với FasL làm hoạt hóa 
caspase 8 và màng tế bào bị co rút lại. Các tác động này được ngăn chặn khi VitC được thêm vào môi trường 
nuôi cấy hoặc các tế bào bị bất hoạt gen cFLIP. Kết quả nghiên cứu cho thấy VitC đã ngăn chặn quá trình 
apoptosis của tế bào tua gây ra bởi FasL thông qua biểu hiện của gen c-FLIP. 
Từ khóa: c-FLIP; tế bào tua; Fas ligand; phosphatidylserine; vitamin C 
 
 
